Measures Finalized in FY
2015 IPPS/LTCH
|
Measure Domain
|
NQF Endorsement Number
|
Measure Name
|
Patient Safety
|
0139
|
Central Line-Associated
Bloodstream Infection (CLABSI)
|
0138
|
Catheter-Associated Urinary
Tract Infection (CAUTI)
|
0753
|
Harmonized Procedure Specific
Surgical Site Infection (SSI) Outcome Measure
|
Cancer Specific Treatment
|
0223
|
Adjuvant Chemotherapy is
considered or administered within 4 months (120 days) of diagnosis
to patients under the age of 80 with AJCC Stage III (lymph node
positive) colon cancer
|
0559
|
Combination Chemotherapy is
considered or administered within 4 months (120 days) of diagnosis
for women under 70 with AJCC T1c, or Stage II or III hormone
receptor negative breast cancer
|
0220
|
Adjuvant Hormonal Therapy
|
Improvement Project
(SCIP)Surgical Care
|
0218
|
Surgery Patients who Received
Appropriate VTE Prophylaxis within 24 Hrs Prior to Surgery to 24
Hrs After Surgery End Time
|
0284
|
Surgery Patients on Beta
Blocker Therapy Prior to Admission who received a Beta Blocker
during the Perioperative Period
|
0453
|
Urinary Catheter Removed on
Post-Operative Day 1 or Post-Operative Day 2 with Day Surgery
Being Day Zero
|
0527
|
Prophylactic Antibiotic
Received Within 1 Hr Prior to Surgical Incision
|
0528
|
Prophylactic Antibiotic
Selection for Surgical Patients
|
0529
|
Prophylactic Antibiotic
Discontinued Within 24 Hrs After Surgery End Time
|
Oncology Care Measures
|
0382
|
Oncology-Radiation Dose Limits
to Normal Tissues
|
0383
|
Oncology: Plan of Care for
Pain
|
0384
|
Oncology: Pain Intensity
Quantified
|
0390
|
Prostate Cancer-Adjuvant
Hormonal Therapy for High-Risk Patients
|
0389
|
Prostate Cancer-Avoidance of
Overuse Measure-Bone Scan for Staging Low-Risk Patients
|
0166
|
HCAHPS Patient Experience of
Care Survey
|
Clinical Effectiveness
|
1822
|
External Beam Radiotherapy
(EBRT)
|